# Starwood Property Trust, Inc.: financial statements, quarterly

STWD · NYSE · CIK 1465128 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stwd.md) · [Financials](/companies/stwd/financials.md) · [Filings](/companies/stwd/filings.md) · [Insiders](/companies/stwd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/stwd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [522](/filings/0001628280-24-045445.md) | [522 d](/filings/0001465128-26-000009.md) | [523](/filings/0001628280-25-024047.md) | [490](/filings/0001465128-25-000010.md) | [480](/filings/0001465128-25-000018.md) | [454 d](/filings/0001465128-26-000009.md) | [418](/filings/0001465128-26-000018.md) | [444](/filings/0001465128-26-000029.md) | [489](/filings/0001465128-25-000018.md) | [493 d](/filings/0001465128-26-000009.md) | [512](/filings/0001465128-26-000018.md) | [514](/filings/0001465128-26-000029.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [368](/filings/0001628280-24-045445.md) | [369 d](/filings/0001628280-24-006128.md) | [356](/filings/0001628280-24-021357.md) | [344](/filings/0001628280-24-034950.md) | [338](/filings/0001628280-24-045445.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(11.4)](/filings/0001628280-24-045445.md) | [18.3 d](/filings/0001465128-26-000009.md) | [1.2](/filings/0001628280-25-024047.md) | [15.9](/filings/0001465128-25-000010.md) | [10.4](/filings/0001465128-25-000018.md) | [(2.1) d](/filings/0001465128-26-000009.md) | [3.8](/filings/0001465128-26-000018.md) | [0.7](/filings/0001465128-26-000029.md) | [13.3](/filings/0001465128-25-000018.md) | [18.9 d](/filings/0001465128-26-000009.md) | [(3.9)](/filings/0001465128-26-000018.md) | [6.2](/filings/0001465128-26-000029.md) |
| Net income | $m | [47.4](/filings/0001628280-24-045445.md) | [71.0 d](/filings/0001465128-26-000009.md) | [154](/filings/0001628280-25-024047.md) | [77.9](/filings/0001465128-25-000010.md) | [76.1](/filings/0001465128-25-000018.md) | [51.6 d](/filings/0001465128-26-000009.md) | [112](/filings/0001465128-26-000018.md) | [130](/filings/0001465128-26-000029.md) | [72.6](/filings/0001465128-25-000018.md) | [96.9 d](/filings/0001465128-26-000009.md) | [51.9](/filings/0001465128-26-000018.md) | [6.6](/filings/0001465128-26-000029.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001628280-24-045445.md) | not reported | [0.48](/filings/0001628280-25-024047.md) | [0.24](/filings/0001465128-25-000010.md) | [0.23](/filings/0001465128-25-000018.md) | not reported | [0.33](/filings/0001465128-26-000018.md) | [0.38](/filings/0001465128-26-000029.md) | [0.19](/filings/0001465128-25-000018.md) | not reported | [0.13](/filings/0001465128-26-000018.md) | [0.01](/filings/0001465128-26-000029.md) |
| Basic EPS | $ per share | [0.15](/filings/0001628280-24-045445.md) | not reported | [0.49](/filings/0001628280-25-024047.md) | [0.24](/filings/0001465128-25-000010.md) | [0.23](/filings/0001465128-25-000018.md) | not reported | [0.33](/filings/0001465128-26-000018.md) | [0.38](/filings/0001465128-26-000029.md) | [0.19](/filings/0001465128-25-000018.md) | not reported | [0.13](/filings/0001465128-26-000018.md) | [0.01](/filings/0001465128-26-000029.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001628280-23-037542.md) | [0.2](/filings/0001628280-25-008420.md) | [0.3](/filings/0001628280-24-021357.md) | [0.3](/filings/0001628280-24-034950.md) | [0.4](/filings/0001628280-24-045445.md) | [0.4](/filings/0001465128-26-000009.md) | [0.4](/filings/0001628280-25-024047.md) | [0.3](/filings/0001465128-25-000010.md) | [0.3](/filings/0001465128-25-000018.md) | [0.5](/filings/0001465128-26-000029.md) | [0.3](/filings/0001465128-26-000018.md) | [0.4](/filings/0001465128-26-000029.md) |
| Total assets | $bn | [70.3](/filings/0001628280-23-037542.md) | [69.5](/filings/0001628280-25-008420.md) | [66.2](/filings/0001628280-24-021357.md) | [64.1](/filings/0001628280-24-034950.md) | [64.2](/filings/0001628280-24-045445.md) | [62.6](/filings/0001465128-26-000009.md) | [62.2](/filings/0001628280-25-024047.md) | [62.4](/filings/0001465128-25-000010.md) | [62.4](/filings/0001465128-25-000018.md) | [63.2](/filings/0001465128-26-000029.md) | [62.1](/filings/0001465128-26-000018.md) | [61.0](/filings/0001465128-26-000029.md) |
| Total liabilities | $bn | [63.2](/filings/0001628280-23-037542.md) | [62.5](/filings/0001628280-25-008420.md) | [59.1](/filings/0001628280-24-021357.md) | [57.1](/filings/0001628280-24-034950.md) | [57.0](/filings/0001628280-24-045445.md) | [55.4](/filings/0001465128-26-000009.md) | [55.0](/filings/0001628280-25-024047.md) | [55.2](/filings/0001465128-25-000010.md) | [54.9](/filings/0001465128-25-000018.md) | [55.7](/filings/0001465128-26-000029.md) | [54.7](/filings/0001465128-26-000018.md) | [53.9](/filings/0001465128-26-000029.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [6.3](/filings/0001628280-23-037542.md) | [6.3](/filings/0001628280-25-008420.md) | [6.3](/filings/0001628280-24-021357.md) | [6.2](/filings/0001628280-24-034950.md) | [6.5](/filings/0001628280-24-045445.md) | [6.4](/filings/0001465128-26-000009.md) | [6.4](/filings/0001628280-25-024047.md) | [6.4](/filings/0001465128-25-000010.md) | [6.9](/filings/0001465128-25-000018.md) | [6.8](/filings/0001465128-26-000029.md) | [6.7](/filings/0001465128-26-000018.md) | [6.5](/filings/0001465128-26-000029.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [356 d](/filings/0001628280-24-045445.md) | [11.9 d](/filings/0001465128-26-000009.md) | [55.9](/filings/0001628280-25-024047.md) | [53.3 d](/filings/0001465128-25-000010.md) | [242 d](/filings/0001465128-25-000018.md) | [296 d](/filings/0001465128-26-000009.md) | [239](/filings/0001465128-26-000018.md) | [(87.4) d](/filings/0001465128-26-000029.md) | [338 d](/filings/0001465128-25-000018.md) | [489 d](/filings/0001465128-26-000009.md) | [93.6](/filings/0001465128-26-000018.md) | [171 d](/filings/0001465128-26-000029.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001465128-26-000009.md) | not reported | not reported | not reported | [0.0 d](/filings/0001465128-26-000009.md) | not reported | not reported |
| Dividends paid | $m | [151 d](/filings/0001628280-24-045445.md) | [151 d](/filings/0001465128-26-000009.md) | [152](/filings/0001628280-25-024047.md) | [153 d](/filings/0001465128-25-000010.md) | [152 d](/filings/0001465128-25-000018.md) | [163 d](/filings/0001465128-26-000009.md) | [162](/filings/0001465128-26-000018.md) | [164 d](/filings/0001465128-26-000029.md) | [165 d](/filings/0001465128-25-000018.md) | [178 d](/filings/0001465128-26-000009.md) | [178](/filings/0001465128-26-000018.md) | [179 d](/filings/0001465128-26-000029.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001465128-26-000018.md) | [0.0 d](/filings/0001465128-26-000029.md) | not reported | not reported | [19.9](/filings/0001465128-26-000018.md) | [10.0 d](/filings/0001465128-26-000029.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [317](/filings/0001628280-23-037542.md) | [309](/filings/0001628280-24-021357.md) | [310](/filings/0001628280-24-034950.md) | [311](/filings/0001628280-24-045445.md) | [331](/filings/0001628280-25-024047.md) | [314](/filings/0001465128-25-000010.md) | [320](/filings/0001465128-25-000018.md) | [335](/filings/0001465128-26-000018.md) | [337](/filings/0001465128-26-000029.md) | [360](/filings/0001465128-25-000018.md) | [367](/filings/0001465128-26-000018.md) | [367](/filings/0001465128-26-000029.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 370,168,950 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001465128-26-000029.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.